Urethral Cancer Associated With Invasive Bladder Cancer

9 clinical trials · Condition

Record	Firm	Date
Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer (NCT01639521)	University of Southern California	2013-05-01
Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer (NCT01611662)	Fox Chase Cancer Center	2012-05-29
Pazopanib in Treating Patients With Metastatic Urothelial Cancer (NCT00471536)	National Cancer Institute (NCI)	2008-08-01
Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function (NCT00478361)	M.D. Anderson Cancer Center	2007-04-01
VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium (NCT00407485)	National Cancer Institute (NCI)	2006-11-01
Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium (NCT00112905)	National Cancer Institute (NCI)	2005-10-01
Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium (NCT00004856)	National Cancer Institute (NCI)	2002-07-01
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074)	National Cancer Institute (NCI)	1999-08-01

Every clearance here is in the API, with alerts when new ones post.